Disruption of the Cockayne Syndrome B Gene Impairs Spontaneous Tumorigenesis in Cancer-Predisposed Ink4a/ARF Knockout Mice
暂无分享,去创建一个
L. Chin | N. Schreiber-Agus | R. Russell | G. V. D. van der Horst | D. Bregman | Prerna Sharma | Hanzhou Lian | Yi Lu
[1] J. Weitzman. Light-induced apoptosis , 2001, Genome Biology.
[2] F. Gruijl,et al. Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice. , 2000, Cancer research.
[3] J. Hoeijmakers,et al. Transcriptional Healing , 2000, Cell.
[4] Philip C. Hanawalt,et al. DNA repair: The bases for Cockayne syndrome , 2000, Nature.
[5] M. Serrano,et al. The INK4a/ARF locus in murine tumorigenesis. , 2000, Carcinogenesis.
[6] E. Friedberg,et al. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. Version 4. , 2000, Mutation research.
[7] A. Sarasin,et al. RETRACTED: Transcription-Coupled Repair of 8-oxoGuanine Requirement for XPG, TFIIH, and CSB and Implications for Cockayne Syndrome , 2000, Cell.
[8] J. Hoeijmakers,et al. Nucleotide excision repair and human syndromes. , 2000, Carcinogenesis.
[9] R. Pestell,et al. Cell cycle regulation and RNA polymerase II. , 2000, Frontiers in bioscience : a journal and virtual library.
[10] J. D. Weber,et al. The ARF/p53 pathway. , 2000, Current opinion in genetics & development.
[11] S. Jackson,et al. Regulation of p53 in response to DNA damage , 1999, Oncogene.
[12] V. Rotter,et al. Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult. , 1999, Experimental cell research.
[13] F. Zindy,et al. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function. , 1999, Cancer research.
[14] L. Chin,et al. Short Dysfunctional Telomeres Impair Tumorigenesis in the INK4aΔ2/3 Cancer-Prone Mouse , 1999, Cell.
[15] W. de Laat,et al. Molecular mechanism of nucleotide excision repair. , 1999, Genes & development.
[16] R. DePinho,et al. The INK4A/ARF locus and its two gene products. , 1999, Current opinion in genetics & development.
[17] F. Chen,et al. Inhibition of RNA polymerase II as a trigger for the p53 response , 1999, Oncogene.
[18] Michael D. Schneider,et al. A Ras-Dependent Pathway Regulates RNA Polymerase II Phosphorylation in Cardiac Myocytes: Implications for Cardiac Hypertrophy , 1998, Molecular and Cellular Biology.
[19] C. Sherr,et al. Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.
[20] L. Chin,et al. The INK4a/ARF tumor suppressor: one gene--two products--two pathways. , 1998, Trends in biochemical sciences.
[21] P. J. van der Spek,et al. Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. , 1998, Molecular cell.
[22] F. Zindy,et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] U. Francke,et al. p48 Activates a UV-Damaged-DNA Binding Factor and Is Defective in Xeroderma Pigmentosum Group E Cells That Lack Binding Activity , 1998, Molecular and Cellular Biology.
[24] E. Friedberg,et al. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage: version 3. , 1998, Mutation research.
[25] J. Hoeijmakers,et al. Biochemical and Biological Characterization of Wild-type and ATPase-deficient Cockayne Syndrome B Repair Protein* , 1998, The Journal of Biological Chemistry.
[26] L. Mullenders,et al. Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema. , 1998, The Journal of investigative dermatology.
[27] Ken Chen,et al. The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53 , 1998, Cell.
[28] M L Agarwal,et al. The p53 Network* , 1998, The Journal of Biological Chemistry.
[29] A. Kansal,et al. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes , 1997, Molecular and cellular biology.
[30] K. Kinzler,et al. The Genetic Basis of Human Cancer , 1997 .
[31] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[32] L. Chin,et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.
[33] A. Sancar,et al. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Hoeijmakers,et al. The Cockayne syndrome B protein, involved in transcription‐coupled DNA repair, resides in an RNA polymerase II‐containing complex , 1997, The EMBO journal.
[35] G. Dianov,et al. Reduced RNA polymerase II transcription in extracts of cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. , 1997, Nucleic acids research.
[36] J. Hoeijmakers,et al. Cockayne syndrome: defective repair of transcription? , 1997, The EMBO journal.
[37] Simon C Watkins,et al. Current Protocols In Cytometry , 1997 .
[38] F. Gruijl,et al. Defective Transcription-Coupled Repair in Cockayne Syndrome B Mice Is Associated with Skin Cancer Predisposition , 1997, Cell.
[39] H. van Steeg,et al. Spontaneous liver tumors and Benzo[a]pyrene‐induced lymphomas in XPA‐deficient mice , 1997, Molecular carcinogenesis.
[40] G. Juan,et al. Analysis of DNA Content and DNA Strand Breaks for Detection of Apoptotic Cells , 1997, Current protocols in cytometry.
[41] J. Cleveland,et al. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis , 1997, Molecular and cellular biology.
[42] S. Clarkson,et al. Defective Transcription-Coupled Repair of Oxidative Base Damage in Cockayne Syndrome Patients from XP Group G , 1997, Science.
[43] R. Halaban,et al. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] E. Friedberg,et al. Cockayne syndrome – a primary defect in DNA repair, transcription, both or neither? , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.
[45] M. Ljungman,et al. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. , 1996, Oncogene.
[46] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[47] N. Iyer,et al. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. , 1996, Biochemistry.
[48] T. Ishikawa,et al. High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene , 1995, Nature.
[49] F. Gruijl,et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA , 1995, Nature.
[50] E. Friedberg,et al. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH , 1995, Cell.
[51] P. Stanley,et al. WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Nitta,et al. Nuclear Accumulation of p53 in Normal Human Fibroblasts Is Induced by Various Cellular Stresses which Evoke the Heat Shock Response, Independently of the Cell Cycle , 1995, Japanese journal of cancer research : Gann.
[53] L. Chin,et al. An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.
[54] T. Sugano,et al. U.v.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. , 1994, Oncogene.
[55] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[56] P. Cooper,et al. Preferential repair of ionizing radiation-induced damage in the transcribed strand of an active human gene is defective in Cockayne syndrome. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[57] L. Donehower,et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.
[58] J. Hoeijmakers,et al. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes , 1992, Cell.
[59] D. Lawrence,et al. Strand-selective repair of DNA damage in the yeast GAL7 gene requires RNA polymerase II. , 1992, The Journal of biological chemistry.
[60] P. Hanawalt,et al. Preferential repair of cyclobutane pyrimidine dimers in the transcribed strand of a gene in yeast chromosomes and plasmids is dependent on transcription. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[61] D. Lawrence,et al. Preferential repair of DNA damage on the transcribed strand of the human metallothionein genes requires RNA polymerase II. , 1991, Mutation research.
[62] K. Kraemer,et al. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum. , 1984, Carcinogenesis.
[63] J. Hoeijmakers,et al. Cancer from the outside, aging from the inside: mouse models to study the consequences of defective nucleotide excision repair. , 1999, Biochimie.
[64] D. Cheo,et al. Database of mouse strains carrying targeted mutations in genes affecting cellular responses to DNA damage. , 1997, Mutation research.
[65] M. Nance,et al. Cockayne syndrome: review of 140 cases. , 1992, American journal of medical genetics.